Variability of the response to activated protein C during normal pregnancy

Blood Coagulation and Fibrinolysis

Volumn 8, Issue 4, 1997, Pages 239-244

  Bokarewa, M I ^a   Wramsby, M ^a   Bremme, K ^a   Blomback M ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Activated protein C; Factor VIII; Normal pregnancy

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 8;

ADULT; ARTICLE; BLOOD CLOTTING; CORRELATION FUNCTION; FEMALE; GENETIC VARIABILITY; HUMAN; NORMAL HUMAN; PREGNANCY; PRIORITY JOURNAL; RISK ASSESSMENT; THROMBOSIS;

EID: 0030852626     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199706000-00005     Document Type: Article

References (29)

1. Bonnar J. Haemostasis and coagulation disorders in pregnancy. In: Bloom AL, Thomas DP, eds. Haemostasis and Thrombosis, 2nd ed. Churchill Livingstone, 1987; 570-584.
2. Blombäck M. Changes in blood coagulation and fibrinolysis during pregnancy and the menstrual cycle: new methods for detecting the changes. Adv Contraception 1991; 7 (suppl 3): 259-272.
3. Hellgren M, Blombäck M. Studies on blood coagulation and fibrinolysis in pregnancy, during delivery and in the puerperium. I. Normal condition. Gynecol Obstet Invest 1981; 12: 141-154.
4. Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognised mechanism characterised by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993; 90: 1004-1008.
5. Koster T, Rosendaal FR, de Ronde H, Briet E, Vanderbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilia study. Lancet 1993; 342: 1503-1507.
6. Svensson PJ, Dahlbäck B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994; 330: 517-522.
7. Bokarewa MI, Blombäck M, Bremme K. Phospholipid antibodies and resistance to activated protein C in women with thrombophilia. Blood Coagul Fibrinol 1995; 6: 417-422.
8. Bertina RM, Koeleman BPC, Koster F, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-67.
9. Zöller B, Svensson P, He X, Dahlbäck B. Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C. J Clin Invest 1994; 94: 2521-2524.
10. Hellgren M, Svensson PJ, Dahlbäck B. Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptives. Am J Obstet Gynecol 1995; 173: 210-213.
11. Bokarewa MI, Blombäck M, Bremme K. Changes in the response to activated protein C during pregnancy. Thromb Haemostasis 1995; 73: 1377 (abstract).
12. 506-Gln mutation in factor V and risk of thrombosis during pregnancy. Br J Haematol 1996; 92: 473-478.
13. Hirsch DR, Mikkola KM, Marks PW, et al. Pulmonary embolism and deep venous thrombosis during pregnancy and oral contraceptive use: prevalence of factor V Leiden. Am Heart J 1996; 131: 1145-1148.
14. Rai R, Regan L, Hadley E, Dave M, Cohen H. Second-trimester pregnancy loss is associated with activated protein C resistance. Br J Haematol 1996; 92: 489-490.
15. Cumming AM, Tait RC, Figes S, Yoong A, Keeney S, Hay CR. Development of resistance to activated protein C during pregnancy. Br J Haematol 1995; 90: 725-727.
16. Mathonnet F, de Mazancourt P, Bastenaire B, et al. Activated protein C sensitivity ratio in pregnant women at delivery. Br J Haematol 1996; 92: 244-246.
17. Schilt AF, Col-de Beys C, Moriau M, Lavenne-Pardonge E. Acquired activated protein C resistance in pregnancy. Thromb Res 1996; 84: 203-206.
18. Gatti L, Tenconi PM, Guarneri D, et al. Hemostatic parameters and platelet activation by flow-cytometry in normal pregnancy: a longitudinal study. Int J Clin Lab Res 1994; 24: 217-219.
19. Justus B, Siegert G, Tiebel O. Changes in the blood coagulation and fibrinolysis system in the course of normal pregnancy. Zentralbl Gynakol 1992; 114: 165-170.
20. Stirling Y, Woolf L, North WRS, Seghatchian MJ, Meade TW. Haemostasis in normal pregnancy. Thromb Haemostasis 1984; 52: 176-182.
21. Vasse M, Leduc O, Borg JY, Chretein MH, Montconduit M. Resistance to activated protein C: evaluation of three functional assays. Thromb Res 1994; 76: 47-59.
22. Cumming AM, Tait RC, Figes S, Hay CR. Diagnosis of APC resistance during pregnancy. Br J Haematol 1996; 92: 1026-1029.
23. Bokarewa MI, Blombäck M. Heterogeneity of the APC-resistance phenomenon. Thromb Res 1994; 75: 395-400.
24. Henkens CMA, Bom VJJ, van der Meer J. Lowered APC-sensitivity ratio related to increased factor VIII-clotting activity. Thromb Haemostasis 1995; 74: 1198-1199.
25. Rao AK, Elliott D, Stadnicki A, DeLa Cadena R. High levels of plasma factor VIIIc impair anticoagulant response to activated protein C. Thromb Haemostasis 1995; 73: 1126 (abstract).
26. Denson KWE, Reed SV, Haddon ME. The modified APC resistance test. Thromb Haemostasis 1995; 74: 995.
27. Koster T, Blann AD, Briet E, Vandenbroucke JP, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 1995; 345: 152-155.
28. Meade TW, Mellows S, Brozovic M, et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; ii: 533-537.
29. Hamsten A, Blombäck M, Wiman B, et al. Haemostatic function in myocardial infarction. Br Heart J 1986; 55: 58-66.